Telomir Pharmaceuticals, Inc. · NASDAQ:TELO
Telomir Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 24 institutions reported holding Telomir Pharmaceuticals, Inc., 4.4% of its shares. Largest: Vanguard, Geode Capital and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Telomir Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 1.9M | 2.6% | +56,987 | Nov 13, 2026 |
| Geode Capital | 438K | 0.59% | +99,385 | Nov 6, 2026 |
| BlackRock | 364K | 0.49% | +83,909 | Nov 13, 2026 |
| Citadel | 146K | 0.20% | +133K | Nov 16, 2026 |
| Northern Trust | 105K | 0.14% | +43,362 | Nov 16, 2026 |
| State Street | 58,600 | 0.08% | no change | Nov 12, 2026 |
| BNY | 51,454 | 0.07% | no change | Nov 5, 2026 |
| Captrust Financial Advisors | 51,194 | 0.07% | no change | Nov 12, 2026 |
| Osaic Holdings, Inc. | 30,990 | 0.04% | −10,500 | Nov 12, 2026 |
| Praetorian Wealth Management, Inc. | 20,000 | 0.03% | no change | Oct 16, 2026 |